
BioEurope Spring, March 23-25, 2026, Lisbon
February 12, 2026/by Ayal Ronen
RNA Leaders Europe, March 17-19, 2026, Vienna
February 12, 2026/by Ayal Ronen
BIO Investment & Growth Summit, March 2-3, 2026, Miami
February 12, 2026/by Ayal Ronen
Investival USA, March 10-11, 2026, Miami
February 12, 2026/by Ayal Ronen
Sachs Associates European Neuroscience Innovation Forum, March 3, 2026, Zurich
February 12, 2026/by Ayal Ronen
Sachs Associates European Life Sciences CEO Forum, March 4-5, 2026, Zurich
February 12, 2026/by Ayal Ronen
The Floodgates are Open: Why Waiting for SBIR Reauthorization is Now a Fiduciary Risk
February 9, 2026/by Ayal Ronen
Show Me the Money – Why Investors Undervalue SBIR Grants
February 3, 2026/by Ayal Ronen
Grant Writing in the Era of AI Workshop at the Non-Dilutive Funding Summit
January 26, 2026/by Ayal Ronen
How to Build a Granting Strategy Workshop at the Non-Dilutive Funding Summit
January 26, 2026/by Ayal Ronen
FreeMind Elite Dionysus Digital Health Presentation at the Non-Dilutive Funding Summit
January 26, 2026/by Ayal Ronen
FreeMind Elite Secretome Therapeutics Presentation at the Non-Dilutive Funding Summit
January 26, 2026/by Ayal RonenSearch
Recent Posts
SBIR Is Back — Here’s What Changed and What You Need to Do NowJune 16, 2026 - 8:03 am
BIO-Europe, November 9-11, 2026, Cologne, GermanyJune 14, 2026 - 7:16 am
SBIR/STTR Program Updates: What Life Science Companies Need to Know in 2026June 2, 2026 - 12:03 pm
RESI San Diego, June 22, 2026 in San DiegoMay 26, 2026 - 9:29 am
CDMRP Funding Opportunities 2026: What Life Science Companies Should Apply ForMay 7, 2026 - 9:35 am
